A preoperative model to predict overall survival in patients with hepatoma undergoing resection
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new preoperative model predicts overall survival (OS) in hepatoma patients undergoing liver resection (LR) better than the BCLC system. This model uses tumor burden score, AFP levels, and cirrhosis to improve survival predictions.
Area Of Science
- Hepatology and Surgical Oncology
- Cancer Prognostics
- Liver Cancer Research
Background
- Hepatoma patients undergoing liver resection (LR) require accurate preoperative prediction of overall survival (OS).
- Existing models may not fully capture prognostic factors for hepatoma patients undergoing LR.
Purpose Of The Study
- To develop and validate a novel preoperative model for predicting OS in hepatoma patients undergoing LR.
- To compare the predictive performance of the new model against the established Barcelona Clinic Liver Cancer (BCLC) staging system.
Main Methods
- Patients with Barcelona Clinic Liver Cancer (BCLC) stage 0, A, or B hepatoma undergoing liver resection were enrolled.
- A Tumor Burden Score (TBS) was calculated using largest tumor size and tumor number.
- Radiographic TBS, alpha-fetoprotein (AFP) levels, and cirrhosis presence were analyzed for association with OS.
Main Results
- Radiographic TBS (low, medium, high), AFP levels (≥400 ng/mL), and cirrhosis were significant predictors of OS.
- The developed simplified risk score demonstrated a superior concordance index (0.688) compared to the BCLC system (0.623).
Conclusions
- A new preoperative model incorporating TBS, AFP, and cirrhosis significantly improves OS prediction in hepatoma patients undergoing LR.
- This model outperforms the current BCLC staging system in predicting survival outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
